Diagnostic Services
Source LDPath produces cutting-edge companion diagnostic predictive and prognostic testing for cancer and other diseases. Our unparalleled combination of expertise in histopathology, coupled with the latest molecular diagnostics, enables us to provide a unique service to support specialist diagnostics.
- Mutation Status Testing (e.g: KRAS/EGFR/BRAF)
- NGS gene panel targeted sequencing
- Personalised Medicine testing (e.g ToxNav)
- Hormone Receptor Testing
- Routine and Specialist Immunohistochemistry Assays (IHC)
- In-situ hybridisation (ISH)
- Circulating Tumour cell assessment (CTC)
Our laboratory is accredited to the ISO15189:2012 – Medical Laboratories standard.
A full list of tests can be found here
When submitting cases to Source LDPath for diagnostic testing portfolio of tests, for example HER2 testing) All cases should be accompanied by a fully completed order form.
Cases submitted as part of the routine reference laboratory portfolio of tests (eg: Her2 IHC) are returned within 5 working days from receipt, with reflex tests (eg: HER2 FISH) turned around in an additional 2 days.
(The majority of Source LDPAth diagnostic tests are performed in our accredited laboratories. However more esoteric or low throughput tests may still be requested and referred to carefully selected third party specialist partner laboratories, where additional TAT may apply).